Marker Therapeutics, Inc. (MRKR)

1.97 -0.22 (-10.05%) USD  |  NASDAQ  |  Jan 22, 12:09
More

Marker Therapeutics Net Preferred Equity Issued (Purchased) (Quarterly)

Net Preferred Equity Issued (Purchased) (Quarterly) Chart

View Net Preferred Equity Issued (Purchased) (Quarterly) for MRKR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Preferred Equity Issued (Purchased) (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Preferred Equity Issued (Purchased) (Quarterly) Range, Past 5 Years

View Net Preferred Equity Issued (Purchased) (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Preferred Equity Issued (Purchased) (Quarterly) Benchmarks

View Net Preferred Equity Issued (Purchased) (Quarterly) Benchmarks
Start Trial
Viridian Therapeutics, Inc. --
ADMA Biologics, Inc. --
Kiniksa Pharmaceuticals International Plc --
Neurocrine Biosciences, Inc. --
AIM ImmunoTech, Inc. --